Growth Metrics

Biogen (BIIB) Minority Interest (2016 - 2023)

Biogen has reported Minority Interest over the past 15 years, most recently at -$4.1 million for Q3 2023.

  • For Q3 2023, Minority Interest rose 52.87% year-over-year to -$4.1 million; the TTM value through Sep 2023 reached -$4.1 million, up 52.87%, while the annual FY2022 figure was -$9.5 million, 114.96% down from the prior year.
  • Minority Interest for Q3 2023 was -$4.1 million at Biogen, up from -$6.4 million in the prior quarter.
  • Over five years, Minority Interest peaked at $462.9 million in Q2 2021 and troughed at -$21.6 million in Q1 2022.
  • A 5-year average of $42.8 million and a median of -$8.7 million in 2022 define the central range for Minority Interest.
  • Biggest five-year swings in Minority Interest: tumbled 375.61% in 2020 and later skyrocketed 3327.14% in 2021.
  • Year by year, Minority Interest stood at -$4.1 million in 2019, then tumbled by 246.34% to -$14.2 million in 2020, then soared by 547.18% to $63.5 million in 2021, then plummeted by 114.96% to -$9.5 million in 2022, then skyrocketed by 56.84% to -$4.1 million in 2023.
  • Business Quant data shows Minority Interest for BIIB at -$4.1 million in Q3 2023, -$6.4 million in Q2 2023, and -$9.6 million in Q1 2023.